QGENRegulationbusinesswire

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

Sentiment:Positive (80)

Summary

(NYSE:QGEN) VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel that sets a new benchmark in the diagnosis of central nervous system (CNS) infections. The QIAstat-Dx system now offers CE-IVDR certified panels for respiratory, gastrointestinal and CNS infections that help clinicians d

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 10, 2025 by businesswire